DK2468256T3 - Kombinationer af vildagliptin og glimepirid - Google Patents

Kombinationer af vildagliptin og glimepirid

Info

Publication number
DK2468256T3
DK2468256T3 DK11194783.4T DK11194783T DK2468256T3 DK 2468256 T3 DK2468256 T3 DK 2468256T3 DK 11194783 T DK11194783 T DK 11194783T DK 2468256 T3 DK2468256 T3 DK 2468256T3
Authority
DK
Denmark
Prior art keywords
vildagliptin
glimepiride
combinations
Prior art date
Application number
DK11194783.4T
Other languages
English (en)
Inventor
Uemit Cifter
Ali Tuerkyilmaz
Basak Acar Karakoey
Mehtap Saydam
Ercan Ergenekon
Original Assignee
Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45319019&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2468256(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from TR2010/10683A external-priority patent/TR201010683A1/xx
Application filed by Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi filed Critical Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi
Application granted granted Critical
Publication of DK2468256T3 publication Critical patent/DK2468256T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C13/00—Cyclic hydrocarbons containing rings other than, or in addition to, six-membered aromatic rings
    • C07C13/28—Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof
    • C07C13/32—Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof with condensed rings
    • C07C13/54—Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof with condensed rings with three condensed rings
    • C07C13/605—Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof with condensed rings with three condensed rings with a bridged ring system
    • C07C13/615—Polycyclic hydrocarbons or acyclic hydrocarbon derivatives thereof with condensed rings with three condensed rings with a bridged ring system with an adamantane ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK11194783.4T 2010-12-21 2011-12-21 Kombinationer af vildagliptin og glimepirid DK2468256T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR2010/10683A TR201010683A1 (tr) 2010-12-21 2010-12-21 Vildagliptin formülasyonları.
TR2011/01809A TR201101809A1 (tr) 2010-12-21 2011-02-24 Vildagliptin ve glimepirid kombinasyonları.

Publications (1)

Publication Number Publication Date
DK2468256T3 true DK2468256T3 (da) 2013-11-11

Family

ID=45319019

Family Applications (1)

Application Number Title Priority Date Filing Date
DK11194783.4T DK2468256T3 (da) 2010-12-21 2011-12-21 Kombinationer af vildagliptin og glimepirid

Country Status (9)

Country Link
EP (1) EP2468256B1 (da)
CY (1) CY1114794T1 (da)
DK (1) DK2468256T3 (da)
ES (1) ES2435966T3 (da)
PL (1) PL2468256T3 (da)
PT (1) PT2468256E (da)
RS (1) RS53033B (da)
SI (1) SI2468256T1 (da)
TR (1) TR201101809A1 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2572704A1 (en) * 2011-09-22 2013-03-27 Sanovel Ilac Sanayi ve Ticaret A.S. Orally-Disintegrating Formulations of Vildagliptin
MA40869A (fr) * 2014-10-30 2017-09-05 Sanovel Ilac Sanayi Ve Ticaret As Combinaisons pharmaceutiques de vildagliptine et d'agonistes de ppar

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2951135A1 (de) 1979-12-19 1981-06-25 Hoechst Ag, 6230 Frankfurt Sulfonylharnstoffe, verfahren zu ihrer herstellung, pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung
JP3465247B2 (ja) 1992-12-28 2003-11-10 アベンティス ファーマ株式会社 動脈硬化症の予防および治療剤
CO5150173A1 (es) 1998-12-10 2002-04-29 Novartis Ag Compuestos n-(glicilo sustituido)-2-cianopirrolidinas inhibidores de peptidasa de dipeptidilo-iv (dpp-iv) los cuales son efectivos en el tratamiento de condiciones mediadas por la inhibicion de dpp-iv
WO2004082591A2 (en) 2003-02-17 2004-09-30 Sun Pharmaceutical Industries Limited Pharmaceutical composition for treatment of diabetes mellitus
GT200600008A (es) 2005-01-18 2006-08-09 Formulacion de compresion directa y proceso
WO2006094942A1 (en) * 2005-03-08 2006-09-14 Nycomed Gmbh Roflumilast for the treatment of diabetes mellitus
US20100034885A1 (en) 2005-06-10 2010-02-11 Combino Pharm, S.L. Formulations containing glimepiride and/or its salts
MY152185A (en) 2005-06-10 2014-08-29 Novartis Ag Modified release 1-[(3-hydroxy-adamant-1-ylamino)-acetyl]-pyrrolidine-2(s)-carbonitrile formulation
KR20090047546A (ko) * 2006-09-07 2009-05-12 니코메드 게엠베하 당뇨병을 위한 조합 치료
CN106177958A (zh) * 2009-02-13 2016-12-07 勃林格殷格翰国际有限公司 包含dpp‑4抑制剂(利拉列汀)任选地组合其它抗糖尿病药的抗糖尿病药物
WO2010107610A1 (en) * 2009-03-17 2010-09-23 Merck Sharp & Dohme Corp. Method for treatment of diabetes and related conditions with combination therapy and compositions containing such compounds
NZ623838A (en) * 2009-04-16 2015-09-25 Taisho Pharmaceutical Co Ltd Pharmaceutical compositions for the treatment of diabetes mellitus

Also Published As

Publication number Publication date
PL2468256T3 (pl) 2014-01-31
ES2435966T3 (es) 2013-12-26
EP2468256B1 (en) 2013-08-21
EP2468256A1 (en) 2012-06-27
PT2468256E (pt) 2013-11-12
RS53033B (en) 2014-04-30
CY1114794T1 (el) 2016-12-14
TR201101809A1 (tr) 2012-07-23
SI2468256T1 (sl) 2013-12-31

Similar Documents

Publication Publication Date Title
DK2691443T3 (da) Konjugerede lipomerer og anvendelser af disse
DK3597644T3 (da) Kationiske aminlipider og anvendelser deraf
DK3333188T3 (da) Anti-NGF-antistoffer og deres anvendelse
DK2675827T3 (da) Hidtil ukendte modulatorer og fremgangsmåder til anvendelse
DK2794654T3 (da) Anti-phf-tau-antistoffer og deres anvendelser
DK3495392T3 (da) Anti-cgrp-sammensætninger og anvendelse deraf
DK3358011T3 (da) Peptid til inducering af regenerering af væv og anvendelse deraf
DK2882496T3 (da) Behandling og diagnosticering af melanom
BR112012017441A2 (pt) compostos e métodos
DK3415157T3 (da) N-acyldipeptidderivater og anvendelser deraf
BR112013007499A2 (pt) piridazinonas - métodos de criação e usos
DK3197164T3 (da) Afkodningsanordning og afkodningsfremgangsmåde
BR112012031446A2 (pt) componentes e métodos para implantes
DK3494972T3 (da) Kombinationer af dolutegravir og lamivudin til behandling af HIV-infektion
DK2536722T3 (da) Bicycliske forbindelser og deres anvendelse som dual-c-src-/jak-inhibitorer
DK2552434T3 (da) Peptider og anvendelse deraf
DK2513193T3 (da) Forbedrede blends af polyarylenethere og polyarylensulfider
DK3392252T3 (da) Pyrimido-pyridazinonforbindelser og deres anvendelse
DK2600715T3 (da) Flydende ST-246-formuleringer og fremgangsmåder
DK3567589T3 (da) Talekoder og talekodningsfremgangsmåde
DK2642992T3 (da) Forbindelser og anvendelse deraf
DK2704744T3 (da) Komplementfaktor-b-analoger og anvendelser deraf
DK2646452T3 (da) Chlorering af carbohydrater og carbohydratderivater
DK2661274T3 (da) Sammensætninger og fremgangsmåder med aloepolysaccharider
DK2501381T3 (da) Behandling af atrieflimmer